These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 26639828)

  • 1. The pharmacokinetics of the β2-adrenoceptor agonist, tulobuterol, in Beagle dogs following transdermal and intravenous administration.
    Kim JH; Kim TH; Park HJ; Choi YJ; Kang JH; Song KH; Koo TS; Seo KW
    Vet J; 2016 Feb; 208():90-2. PubMed ID: 26639828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pharmacokinetics of the beta 2-adrenoceptor agonist, tulobuterol, given transdermally and by inhalation.
    Uematsu T; Nakano M; Kosuge K; Kanamaru M; Nakashima M
    Eur J Clin Pharmacol; 1993; 44(4):361-4. PubMed ID: 8099880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioequivalence assessment of tulobuterol transdermal delivery system in healthy subjects
.
    Park SI; Kim BH
    Int J Clin Pharmacol Ther; 2018 Aug; 56(8):381-386. PubMed ID: 29932416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alteration of the circadian rhythm in peak expiratory flow of nocturnal asthma following nighttime transdermal beta2-adrenoceptor agonist tulobuterol chronotherapy.
    Burioka N; Miyata M; Endo M; Fukuoka Y; Suyama H; Nakazaki H; Igawa K; Shimizu E
    Chronobiol Int; 2005; 22(2):383-90. PubMed ID: 16021849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transdermal tulobuterol patch, a long-actingβ(2)-agonist.
    Tamura G; Ichinose M; Fukuchi Y; Miyamoto T
    Allergol Int; 2012 Jun; 61(2):219-29. PubMed ID: 22270072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of bronchodilatory properties of transdermal and inhaled long-acting beta 2-agonists.
    Yamagata T; Hirano T; Sugiura H; Yanagisawa S; Ichikawa T; Ueshima K; Akamatsu K; Nakanishi M; Matsunaga K; Minakata Y; Ichinose M
    Pulm Pharmacol Ther; 2008; 21(1):160-5. PubMed ID: 17632023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the effects of tulobuterol patch and salmeterol in moderate to severe asthma.
    Nishiyama O; Taniguchi H; Kondoh Y; Kimura T; Kato K; Kume H; Shimokata K
    Clin Exp Pharmacol Physiol; 2006 Nov; 33(11):1016-21. PubMed ID: 17042908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Case of Congenital Complete Atrioventricular Block Treated with Transdermal Tulobuterol.
    Ikuta T; Fujioka K; Sato Y; Ashina M; Fukushima S; Ohyama S; Okubo S; Yamana K; Morizane M; Tanimura K; Deguchi M; Iijima K; Morioka I; Yamada H
    Kobe J Med Sci; 2018 Apr; 63(4):E109-E112. PubMed ID: 29955022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Additive effects of transdermal tulobuterol to inhaled tiotropium in patients with COPD.
    Ichinose M; Seyama K; Nishimura M; Fukuchi Y; Nagai A; Mishima M; Kubo K;
    Respir Med; 2010 Feb; 104(2):267-74. PubMed ID: 19875277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment with beta2-adrenoceptor agonist in vivo induces human clock gene, Per1, mRNA expression in peripheral blood.
    Burioka N; Takata M; Endo M; Miyata M; Takeda K; Chikumi H; Tomita K; Fukuoka Y; Nakazaki H; Sano H; Shimizu E
    Chronobiol Int; 2007; 24(1):183-9. PubMed ID: 17364588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and pharmacodynamics of the tulobuterol patch, HN-078, in childhood asthma.
    Iikura Y; Uchiyama H; Akimoto K; Ebisawa M; Sakaguchi N; Tsubaki T; Ishizu H; Kabayama H; Yagi K; Miura K
    Ann Allergy Asthma Immunol; 1995 Feb; 74(2):147-51. PubMed ID: 7697473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of patch formulation of tulobuterol, a long-acting beta2-adrenoreceptor agonist, in the treatment of severe pediatric asthma.
    Yoshihara S; Yamada Y; Abe T; Arisaka O
    Ann Allergy Asthma Immunol; 2006 Jun; 96(6):879-80. PubMed ID: 16802779
    [No Abstract]   [Full Text] [Related]  

  • 13. Addition of transdermal or inhaled long-acting Beta2-agonists in adult asthmatic patients treated with inhaled corticosteroids: switchover study from tulobuterol patch to salmeterol dry powder inhaler.
    Kobayashi Y; Yasuba H; Kudou M; Kita H
    J Asthma; 2007 Mar; 44(2):77-81. PubMed ID: 17454319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative study of skin permeation profiles between brand and generic tulobuterol patches.
    Yoshihara S; Fukuda H; Abe T; Arisaka O
    Biol Pharm Bull; 2010; 33(10):1763-5. PubMed ID: 20930390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of the bronchodilator tulobuterol in man after repeated oral doses.
    Chasseaud LF; Wood SG
    J Int Med Res; 1986; 14(5):223-7. PubMed ID: 3770288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Skin permeability of tulobuterol in two transdermal formulations and their followability.
    Takizawa Y; Goto T; Sato S; Ohmori N; Mori K; Shimada Y; Chen K; Miyagi T; Fukai F
    Drug Discov Ther; 2017 Nov; 11(5):253-258. PubMed ID: 29021505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical application of transdermal beta-2 agonists for the wheezing diseases in childhood].
    Hong JG; Li Z
    Zhonghua Er Ke Za Zhi; 2013 Feb; 51(2):106-8. PubMed ID: 23527972
    [No Abstract]   [Full Text] [Related]  

  • 18. Improvement of pulmonary function and dyspnea by tiotropium in COPD patients using a transdermal beta(2)-agonist.
    Akamatsu K; Yamagata T; Takahashi T; Miura K; Maeda S; Yamagata Y; Ichikawa T; Yanagisawa S; Ueshima K; Hirano T; Nakanishi M; Matsunaga K; Minakata Y; Ichinose M
    Pulm Pharmacol Ther; 2007; 20(6):701-7. PubMed ID: 17049894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta-agonistic properties of tulobuterol, a new beta-sympathicomimetic drug, and its effects on pulmonary beta-adrenoceptor characteristics.
    Terpstra GK; Raaijmakers JA
    Lung; 1990; 168 Suppl():179-85. PubMed ID: 1974673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beta-2 adrenergic responses to tulobuterol in airway smooth muscle, vascular smooth muscle and adrenergic nerves.
    Ruff F; Zander JF; Edoute Y; Santais MC; Flavahan NA; Verbeuren TJ; Vanhoutte PM
    J Pharmacol Exp Ther; 1988 Jan; 244(1):173-80. PubMed ID: 2826765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.